mitotane and cabazitaxel

mitotane has been researched along with cabazitaxel in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abate, A; Ambrosini, R; Berruti, A; Canu, L; Cosentini, D; Ferrari, VD; Gianoncelli, A; Grisanti, S; Laganà, M; Sigala, S; Terzolo, M; Tiberio, GAM; Turla, A; Zamparini, M1

Trials

1 trial(s) available for mitotane and cabazitaxel

ArticleYear
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma.
    ESMO open, 2022, Volume: 7, Issue:2

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Humans; Mitotane; Taxoids

2022